Doyle Mittie 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Doyle Mittie（CIK 1918845）在 1 家公司共报告 37 笔 SEC Form 4 内部人交易（最近一笔 2026-09-01）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-09-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 679 | $13,580 |
| 2026-08-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 1,000 | $12,650 |
| 2026-08-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 1,000 | $20,000 |
| 2026-08-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-08-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 679 | $13,580 |
| 2026-07-29 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 1,000 | $12,650 |
| 2026-07-29 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 1,000 | $20,000 |
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 2,875 | $36,369 |
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 1,779 | $14,303 |
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 4,654 | $93,080 |
| 2026-06-25 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 1,450 | $26,100 |
| 2026-06-25 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 1,450 | $11,658 |
| 2026-06-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 1,084 | $14,200 |
| 2026-06-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-06-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 679 | $10,864 |
| 2026-05-26 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 43,500 | $0 |
| 2026-05-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 3,000 | $37,950 |
| 2026-05-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 3,000 | $56,280 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 1,000 | $12,650 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 679 | $5,459 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 1,679 | $26,864 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 77,905 | $985,498 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 买入 | 28,650 | $230,346 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | 卖出 | 27,538 | $496,510 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01